Fogorvosi szemle, 2018 (111. évfolyam, 1-4. szám)

2018-03-01 / 1. szám

22

FOGORVOSI SZEMLE

30. Ebstein JB, Gorsky IVI, Cabay RJ: Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma. Role of primary care physicians. Can Fam Physician. 2008; 54: 870-875.

31. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H etal: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013; 49: 1374-1403.

32. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. CA Cancer J Clin. 2000; 92: 709-720.

33. Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004; 31: 744-754.

34. Gômez I, Warnakulasuriya S, Varela-Centelles Pl, López-Jornet P, Suárez-Cunqueiro M, Diz-Dios P et al: Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay? Oral Dis. 2010; 16: 333-342.

35. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, James PD et al: Randomised controlled trial of fecal occult blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.

36. Hakama M: Trends in the Incidence of Cervical Cancer in the Nordic Countries. In: Magnus K, ed. Trends in cancer incidence. Washington, DC, Hemisphere. 1982; 279-292.

37. Hayes RB, Bravo-Ottero E, Kleinman DV, Brown LM, Fraumeni JF Jr, Harty LC et al: Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes and Control. 1999; 10: 27-33.

38. Hofmann T, Tillonen J, Pitmaki H, Salaspuro M, Lindqvist C, Meurman JH: Poor dental status increases acetaldehyd-production from etanol in saliva: a possible link to increased oral cancer risk in heavy drinkers. Oral Cancer. 2001; 37: 153-158.

39. Hutás I: Ernyőfényképszűrő vizsgálathoz csatlakozó komplex szűrés. Orvosi Hetilap. 1975; 116: 1516-1518.

40. Iarc Multicenter Oral Cancer Study Group: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772- 1783.

41. Ismail Al, Jedele JM, Lim S, Tellez M: A marketing campaign to promote screening for oral cancer. J Am Dent Assoc. 2012; 143: e57-66.

42. Jaber MA, Porter SR, Gilthrope MS, Bedi R, Scully C: Risk factors for oral epithelial dysplasia - the role of smoking et alcohol. Oral Oncol. 1999; 35:151-156.

43. Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC et al: Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011; 23: 237-246.

44. Johnson S, McDonald JT, Corsten M: Oral cancer screening and socioeconomic status. J Otolaryngol Head Neck Surg. 2012; 41 : 102-107.

45. Kardos L, Pácz M, Erményi I, Nemes I: Stomatoonkológiai szűrővizsgálat önként jelentkezőkön. Magyar Onkológia. 2000; 44: 145-147.

46. Kerr AR, Changrani JG, Gany FM, Gany FM, Cruz GO: An academic dental center grapples with oral cancer disparities: current collaboration and future opportunities. J Dent Educ. 2004; 68 (5): 531-541.

47. Kronborg, O, Fenger C, Olsen, J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecalt occult blood test. Lancet. 1996; 348: 1467-1471.

48. Kongevinas M, Pearce N, Susser M, Boffeta P (EDS): Social inequities and cancer IARC. Sci Publ. 138. Lyon. 1997.

49. Kujan O, Glenny A, Duxbury J, Thakker, N, Sloan P: Evaluation of screening strategies for improving oral cancer mortality: a Cochrane Systematic Review. J Dent Educ. 2005; 69: 255-265.

50. Kujan O, Sloan PH: Dilemmas of oral cancer screening: an update. Asian Pacific J Cancer Prev. 2013; 14: 3369-3373.

111. évf. 1. sz. 2018.

51. Kujan OB: What dentists should know about oral cancer screening? Eur. J Gen Dentist. 2013; 2: 229-234.

52. Läära E, Day NE, Hakama M: Trends in mortality in the Nordic countries: association with organised screening programmes. Lancet. 1988; 1: 1247-1249.

53. Lalond M: A new perspective on the health of Canadians. A working document. Information Canada. 1974.

54. Lehew, CW, Epstein, JB, Koerber, A: Training in the primary prevention and early detection of oral cancer: Pilot study of its impact on clinicians’ perceptions and intentions. Ear Nose Throat J. 2002; 88(1): 748-753.

55. Mandel JS, Bond JH, Church TR: Reduction of mortality frrom colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993; 329(9): 1365-1371.

56. MacPherson LMD, McCann MF, Gibson J, Binnie VI, Stephen KW: The role of primary health care professionals in oral cancer prevention and detection. Brit Dental J. 2003; 195(5): 277-281.

57. Marques LA, Rejane JE, Figueiredo AO, Góis-Filho JF, Kowalski LP, De Carvalho MB et al: Oral health, hygiene practices and oral cancer. Rev Saúde Pública. 2008; 42(3): 471-479.

58. McGurk M, Scott SE: The reality of identifying early oral cancer in the general dental practice. Brit Dental J. 2010; 208(8): 347-351.

59. Morrison AS: Introduction. In: Screening in chronic disease. 2nd ed. New York (NY): Oxford University Press. 1992; 3-20.

60. Moyer VA on behalf of the U.S.: Preventive Services Task Force. Screening for Oral Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern (ed). 2014; 160: 55-60.

61. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis, Let AL: Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control. 2007; 18(9): 919-929.

62. Nagao T, Ikeda N, Fukano H, Miyazaki H, Warnakulasuriya S, Ikeda N, Fukano H: Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000; 36: 340-346.

63. Napier SS, Speight PM: Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008; 37: 1-10.

64. Nemes JA: Szájüregi laphámrákok vizsgálata az észak-kelet magyarországi régióban. Etiológiai és prognosztikai faktorok. PhD tézisek, DEOEC. 2006.

65. Németh Zs, Szabó Gy, Bogdán S: A szájüregi daganatok megelőzése, szűrése. Hippocrates. 2010; 1: 52-55.

66. Olson CM, Burda U, Beil T, Whitlock EP: Screening for Oral Cancer. A targeted evidence update for the U.S. Preventive Services Task Force Evidence Syntheses. No. 102. Agency for Healthcare Research and Quality (US). 2013. Apr; Report No. 13-05186-EF-1 USPSTF Evidence

67. Orbak R, Bayraktar C, Kavrut F, Gündogdu C: Poor oral hygiene and dental trauma as the precipitating factors of squamous cell carcinoma. Oral Oncology Extra. 2005; 41: 109-113.

68. Orosz M, Gábris K: A hazai klinikai fogászati higiénikus szakképzés elmúlt tíz éve ÍME 6: 2007; 30-33.

69. Peacock ZS, Pogrel MA, Schmidt BL: Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc. 2008; 139: 1346-1352.

70. Rethman MP, Carpenter W, Cohen EEJ on behalf of American Dental Association: Evidence-based clinical recommendations reqardinq screening for oral squamous cell carcinomas. 2010; 141: 509-520.

71. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M et al: Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000; 88: 664-673.

72. Sankaranarayanan R, Ramadas K, Thomas G, Thara S, Mathew B, Rajan B et al: Effect of screening on oral cancer mortality in Kera-